NEWS: Political Activist Filmmaker Kevin Booth Retained by Cannabis Science to Film Specialty Documentary

Doc Herbalist with Kevin Booth (right)

Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to announce that the company has retained filmmaker Kevin Booth to collaborate on a documentary researching cannabis as a medicine and the truth behind the science of marijuana.

Many people know Kevin Booth’s work with the late comedian, Bill Hicks. Kevin produced most of Bill’s CDs and videos that led to the comedian’s own HBO specials and multiple appearances on David Letterman. The story of Kevin’s seventeen-year friendship and working partnership with Bill Hicks was recently explored in a feature length BBC documentary that just ended a year long run of festivals and theatrical screenings. After Bill’s death from pancreatic cancer in 1994, Kevin’s filmmaking took on a political turn and he produced documentaries with talk show host Alex Jones about the incident in Waco, Texas, the American two-party political system, and 9/11. In 2005, Kevin traveled to the UK in order to promote his book titled “Agent of Evolution” about his friendship with Bill Hicks - published by Harper Collins.

Several of Kevin’s family members died as a result of alcohol, tobacco, and pharmaceutical use. In 2003 Kevin began investigating the drug war in the United States and produced the documentary “American Drug War: The Last White Hope.” In his investigations, he discovered the United States government considers marijuana more dangerous than crack cocaine or crystal meth. Kevin sought to separate fact from fiction by traveling across the United States, documenting the “fallout” from the War on Drugs and seeking possible solutions and alternatives that have worked elsewhere. Kevin has toured the country, showing his film and lecturing at universities in hope of sparking a meaningful debate. “American Drug War” won best feature documentary at several film festivals from coast to coast and aired continuously on the Showtime network between 2008-2010. During this same time the film was also broadcasted on major networks in Canada, Australia, Poland, Lebanon and South Africa. Kevin recently returned from filming in Juarez Mexico for the follow up to “American Drug War" and is aiming for the sequel’s release later this year.

Kevin Booth’s body of work also include “How Weed Won the West" (a light hearted and humorous look into the California Cannabis culture) “Bill Hicks - Sane Man”, multiple music videos, feature length comedy concerts of Bill Hicks, Fear Factor’s Joe Rogan and groundbreaking comic Doug Stanhope. Kevin’s production of the Hick’s CD “Rant in E Minor” was recently awarded the 11th best comedy album of all time by Spin magazine competing against Bill Cosby, Chris Rock, Lenny Bruce, Rodney Dangerfield, Eddie Murphy, Sam Kinison, Woody Allen, George Carlin and Richard Pryor just to mention a few. Kevin’s audio productions “Rant in E Minor”, “Arizona Bay” and “Marble Head Johnson” all contain music written and performed by Kevin Booth and Bill Hick who first started playing music together in a high school punk-rock band named STRESS.

Today Kevin runs Sacred Cow Productions dba SCP Enterprises and self distributes through his own sites including SacredCow.com, AmericanDrugWar.com and Amazon. Several of his titles can be found distributed through Warner Brothers and Gravitas VOD that has now broken Booth’s work into the Latin market on both Netflix and ITUNES.

As previously announced, Cannabis Science has begun pre-production of its documentary, in which prohibition of marijuana, medicinal benefits of the plant, and international medical marijuana programs will be explored. Booth’s interests and demonstrated experience will be a true asset to Cannabis Science’s endeavors. The documentary will expose audience members to the subject of medical marijuana so that they may gain a better understanding of the research, science, and planning that goes into running Cannabis Science, one of the top marijuana research companies. The documentary will teach viewers about the medicinal benefits for a wide variety of conditions and show them that prohibition is unnecessary. This is clearly a topic for which Kevin Booth will provide great assistance, and Cannabis Science is excited to begin this project.

Source: MarketWatch.com

NEWS: Cannabis Science, Inc. Begins Pre-Production of Groundbreaking Cannabis Television Documentary

COLORADO SPRINGS, Colo., (BUSINESS WIRE) -- Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is excited to be embarking on a medical marijuana documentary project. Pre-production of this groundbreaking educational film is currently underway.

Many documentaries about marijuana have been made, typically focusing on getting high or the medicinal effects and benefits. Cannabis Science will be first documentary to focus on the science behind medicinal cannabis, including untangling the history of marijuana's reputation, the improvement it can bring to people's daily lives, and what breakthroughs could be on the horizon for this emerging industry.

Modern science supports a long list of illnesses that cannabis can treat: Multiple Sclerosis, Cancer, Arthritis, HIV/Aids, Asthma, Alzheimer's Disease, Anti-aging, Auto Immune Disease, brain trauma (closed head injury), Crohn's Disease, chronic pain management, Diabetes, digestive illnesses, Gastro Intestinal Reflux Disease (GERD), high blood pressure, Glaucoma, Influenza, Methicillin-Resistant Staphylococcus Aureus (MRSA), Post Traumatic Stress Disorder (PTSD), Tourette Syndrome, and Irritable Bowel Syndrome (IBS), etc. The science gives a foundation for understanding the broad spectrum of benefits that can be achieved by increasing the cannabinoid activity in people suffering from so many illnesses.

Part of the science that will be explored are the various forms marijuana can take as a medication, including edibles, pills, liquids, and strips that dissolve on the tongue. The documentary will investigate how these forms are processed in the body and can reverse or minimized the effects of disease. Cannabis Science is first and foremost a "patient orientated company." Therefore, patients will be interviewed, giving the audience a glimpse at the real, positive benefits the medicine provides for those with chronic illness, as opposed to the prevailing and false belief that marijuana is addictive and even harmful.

Other documentaries showcase marijuana culture, likening it to the popular view of the 1960s and marijuana use running rampant among the hippie population. Cannabis Science's documentary, however, will show cannabis in a positive light and demonstrate that what has been, and is, taught by prohibitionists is false, and ignores modern science, history, and the voice of patients. The documentary will also focus on the co-founders of Cannabis Science, how the company is working to target critical illnesses, conducting much needed research, and is developing cannabis-based medications. The audience will hear the views of doctors who have discovered for themselves through treating patients the amazing benefits that cannabis based medicines can provide for their patients.

While the main focus of the documentary is not political, learning the truth about the science of cannabinoids will educate the public on the damage caused by prohibition. Patients whose circumstances could have drastically improved and who could have reduced the severity of their illnesses much earlier from medical marijuana will be interviewed. The film will explore the reasons behind the delay in world governments opening up to the idea that medical marijuana is a beneficial reality.

Source: Market Watch

NEWS: Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility

COLORADO SPRINGS, Colo., Dec. 14, 2010 /PRNewswire/ -- Cannabis Science, Inc. (OTC Bulletin Board: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce it has signed a lease for a new corporate headquarters as its new base of operations in Denver, Colorado. The 6,600 sq. ft. core facility at 2422 S. Trenton Way, Unit H will be dedicated to housing executive offices, administrative personnel, as well as the Lab Division core of operations for its cannabis formulations testing and FDA initiatives.

"Needless to say we are very happy that with the support and patience of our investors we have achieved this milestone. This facility will be the Cannabis Science core and is an instrumental step in accomplishing our short and long-term goals of carrying out the basic and applied research needed to provide the best Cannabis Science products to patients. Uniquely, Cannabis Science will serve both the dispensary market, through licensing our technologies and analytical capabilities, and the pharmaceutical market, by working through the FDA approval process," stated Dr. Robert Melamede, CEO.

The company has executed a five-year lease on the facility in order to provide stable growth during our development phase. In our new corporate headquarters, the Company will facilitate customer communications while we mature our operations. Up till now, the Company has focused on developing out corporate structure and preliminary financial base. We now have the facility to centralize and expand our staff. As we expand our infrastructure, we will be more responsive to the overwhelming number of inquiries that we receive from patients, investors and the media.

The new laboratory facility will include analytical chemistry and genetic instrumentation, extraction equipment, as well as genetic and cell culture facilities. Our intent is to meet or exceed all federal, state, and local regulatory requirements particularly with respect to meeting FDA standards. Cannabis Science is currently working diligently to proceed down the FDA regulatory path. Our new facility will expedite this process.

Cannabis Science previously announced, on 8 July 2010, the execution of a lease on a 9,500 square foot facility in Denver that is now solely housing the grow operation of its licensed partner Rockbrook, Inc., in compliance with the current licensing requirements of the State of Colorado for a horticulture facility, infused products facility, and medical cannabis dispensary.

About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Source: PR Newswire